-
Letter: Reassessing Tenofovir Alafenamide Use Throughout Pregnancy—A New Horizon in Hepatitis B Therapy Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2025-06-03
Ashish Kumar VyasWe read with interest the study by Pan et al. on tenofovir alafenamide (TAF) therapy throughout pregnancy in mothers with chronic hepatitis B (CHB) [1]. This well-designed study, employing propensity score matching and subgroup analyses, provides reassuring evidence on TAF safety across all trimesters, demonstrating effective reduction of maternal hepatitis B virus (HBV) DNA levels and prevention of
-
Breath Testing for Colorectal Cancer Detection in Patients With a Positive Fecal Immunochemical Test: A Multicentre Prospective Cross-Sectional Study With External Validation Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2025-06-03
Milou L. M. van Riswijk, Kelly E. van Keulen, Adriaan C. I. T. L. Tan, Ruud W. M. Schrauwen, Wouter H. de Vos tot Nederveen Cappel, Peter D. Siersema -
Letter: Reassessing Tenofovir Alafenamide Use Throughout Pregnancy—A New Horizon in Hepatitis B Therapy. Authors' Reply Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2025-06-03
Xingfei Pan, Calvin Q. PanWe are grateful to Dr. Vyas [1] for his thoughtful comments and insights in response to our recent publication [2]. We fully agree with his perspective that treatment decisions in this context must be individualised and guided by ALT, HBeAg status, HBV DNA levels, and fibrosis scores. As pregnancy progresses, physiological changes impose an increasing burden on the maternal liver, often exacerbating
-
Is the Molecular Classification of ERBB2 in Stage III Colon Cancer Clinically Ready? Gastroenterology (IF 25.7) Pub Date : 2025-06-04
Jianwei LiuNo Abstract
-
Are ERBB2 RNA-High, Amplification-Negative Tumors a Missed Opportunity for Targeted Therapy? Gastroenterology (IF 25.7) Pub Date : 2025-06-04
Zemin Tian, Yinde Huang, Yuan QiuNo Abstract
-
The gut microbiome connects nutrition and human health Nat. Rev. Gastroenterol. Hepatol. (IF 45.9) Pub Date : 2025-06-04
Yolanda Sanz, John F. Cryan, Mélanie Deschasaux-Tanguy, Eran Elinav, Rebekka Lambrecht, Patrick Veiga -
Public health policies to prevent alcohol-related liver disease Nat. Rev. Gastroenterol. Hepatol. (IF 45.9) Pub Date : 2025-06-04
Richard Parker, Juan P. Arab, Jeffrey V. Lazarus, Ramon Bataller, Ashwani K. Singal -
Differential HCC risk among HBV indeterminate types at baseline and by phase transition Gut (IF 23.0) Pub Date : 2025-06-04
Rui Huang, Huy N Trinh, Satoshi Yasuda, Angela Chau, Mayumi Maeda, Ai-Thien Do, Daniel Q Huang, Takanori Ito, Takashi Honda, Masatoshi Ishigami, Ritsuzo Kozuka, Carmen Monica Preda, Cheng-Hao Tseng, Sebastián Marciano, Pei-Chien Tsai, Dong Hyun Lee, Christopher C Wong, Son Do, Keigo Kawashima, Jian Zhang, Raluca Ioana Marin, Irina Sandra, Jiayi Li, Eiichi Ogawa, Ramsey Cheung, Jie Li, Ming-Lung YuBackground Patients with chronic hepatitis B (CHB) with indeterminate phase make up a diverse cohort with likely different outcomes. Objective We compared the hepatocellular carcinoma (HCC) risk in indeterminate CHB with different baseline types and by phase transition. Design This was a retrospective cohort study of 1986 (94.2% Asian) patients with indeterminate CHB from nine countries/regions. Patients
-
Early metabolic fate commitment in pancreatic neoplastic precursors Gut (IF 23.0) Pub Date : 2025-06-04
Anna Härle, Alexander KlegerWith a devastating 5-year survival rate of only 8%, pancreatic ductal adenocarcinoma (PDAC) is among the deadliest cancers and is expected to become the second leading cause of cancer-related deaths in the USA by 2030.1 2 Thus, the deciphering of key events driving tumour development and progression in both early and late stages of PDAC is crucial for improving diagnosis, therapy, and potentially prevention
-
Response to the letter to the editor ‘revisiting lipid dysregulation in colorectal cancer: critical appraisal of pro-inflammatory bias and therapeutic implications’ Gut (IF 23.0) Pub Date : 2025-06-04
Ramani Soundararajan, Ganesh Halade, Timothy J YeatmanWe would like to thank the author Xudong Zhu for his interest in our work.1 Herein, we will address the identified concerns. From the outset, the letter provides a very high level, cursory critique, without supporting data or new insights revealing numerous weaknesses to buttress the author’s arguments, while raising a number of new, unfocused questions that are beyond the scope of the article. The
-
Histone lactylation-driven feedback loop modulates cholesterol-linked immunosuppression in pancreatic cancer Gut (IF 23.0) Pub Date : 2025-06-04
Jing Yang, Xiaoning Yu, Mingming Xiao, He Xu, Zhen Tan, Yubin Lei, Yanmei Guo, Wei Wang, Jin Xu, Si Shi, Xianjun YuBackground Pancreatic cancer exhibits limited clinical responses to immunotherapy, highlighting the need for new strategies to counteract its immunosuppressive microenvironment. Although metabolic reprogramming and epigenetic changes contribute to malignancy, the impact of lactate-driven histone lactylation on the tumour microenvironment (TME) has not been fully explored. Objective This study aims
-
DUOX2-mediated gut barrier dysfunction: a preclinical mechanism in IBD pathogenesis? Gut (IF 23.0) Pub Date : 2025-06-04
Cong Phi Dang, Kenneth Croitoru, Williams TurpinInflammatory bowel disease (IBD) is characterised by dysregulated chronic inflammation throughout the intestinal tract with unknown causes. Aetiology of IBD is speculated to be the result of a complex interplay among genetic predisposition, dysregulated immune response, gut microbiome and environmental factors. Despite the identification of various risk genes, a substantial impact of genetic risk on
-
Prophylactic clip closure after endoscopic submucosal dissection of large flat and sessile colorectal polyps: a multicentre randomised controlled trial (EPOC trial) Gut (IF 23.0) Pub Date : 2025-06-03
Akihiro Miyakawa, Yuzuru Tamaru, Takeshi Mizumoto, Noriyoshi Kanazawa, Shiori Uchiyama, Kosuke Maehara, Yorinobu Sumida, Akira Nakamura, Ei Itobayashi, Haruhisa Shimura, Yoshio Suzuki, Tomoyuki Akita, Kenji Shimura, Toshio KuwaiBackground Prophylactic clip closure after endoscopic mucosal resection reduces delayed bleeding in large and proximal colon lesions; however, evidence regarding its effectiveness in colorectal endoscopic submucosal dissection (ESD) is lacking. Objective To compare clinically significant delayed bleeding rates between a clip closure and a control group for flat and sessile 20–50 mm colorectal polyps
-
Safety and efficacy of MEK inhibitor treatment for gastric pre-cancerous lesions Gastroenterology (IF 25.7) Pub Date : 2025-06-03
James R. Goldenring, Bogun Jang, Takuji Gotoda, Naoyuki Yamaguchi, Eunyoung Choi, Sachiyo NomuraNo Abstract
-
Skipping surgery in rectal and other solid cancers with mismatch repair deficiency using immunotherapy Gastroenterology (IF 25.7) Pub Date : 2025-06-02
Maria D. GiraldezNo Abstract
-
Toxic microbiome and progression of chronic kidney disease: insights from a longitudinal CKD-Microbiome Study Gut (IF 23.0) Pub Date : 2025-06-03
Manolo Laiola, Laetitia Koppe, Amine Larabi, Florence Thirion, Céline Lange, Benoit Quinquis, Aymeric David, Emmanuelle Le Chatelier, Berengere Benoit, Giuseppina Sequino, Stephanie Chanon, Aurelie Vieille-Marchiset, Yves-Edouard Herpe, Jean-Claude Alvarez, Griet Glorieux, Hubert Krukowski, Huys R B Geert, Jeroen Raes, Denis Fouque, Ziad A Massy, Stanislav Dusko Ehrlich, Bénédicte Stengel, Sandra WagnerBackground The gut microbiota has been linked to non-communicable diseases, including chronic kidney disease (CKD). However, the relationships between gut microbiome composition changes, uraemic toxins (UTs) accumulation, and diet on CKD severity and progression remain underexplored. Objective To characterise relationships between gut microbiome composition and functionality, UTs diet, and CKD severity
-
Presinusoidal portal hypertension with cutaneous vascular malformations Gut (IF 23.0) Pub Date : 2025-06-02
Xian Xing, Si-Di Wang, Jin-Lin Yang, Zhu WangA 24-year-old man presented with a 7-year history of recurrent melena, acutely worsening 3 days prior. He had undergone endoscopic band ligation and glue sclerotherapy for gastro-oesophageal varices, yet intermittent bleeding persisted without advanced aetiological evaluation beyond cirrhosis/thrombosis screening. Physical examination revealed distinctive congenital capillary abnormalities, including
-
Exploring the etiology of colitis: insights from gut microbiota research Gut Microbes (IF 12.2) Pub Date : 2025-06-03
Guanru Qian, Xiaolin Chen, Gang Liu, Jiankang Yu, Sijia Zhong, Jiaxi Yang, Yefei Sun, Jianping Zhou -
Occurrence and Management of Opportunistic Infections in Patients With Autoimmune Hepatitis: A Spanish Multicentre Study Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2025-06-03
María Del Barrio, Elena Ferreiro, Elena Gómez, Arantxa Caballero, Magdalena Salcedo, Alvaro Santos‐Laso, Andrea González‐Pascual, José Manuel Sousa, Judith Gómez, Indhira Pérez‐Medrano, Marta Quiñones Calvo, Conrado Fernández‐Rodriguez, Beatriz Mateos, Ana Arencibía, Mar Riveiro‐Barciela, Ignacio Vaz‐Romero, Diana Horta, Isabel Conde, Ismael El Hajra, Manuel Rodríguez‐Perálvarez, Marina Orti Cuerva -
Higher Prescribed Opioid Use Among Adults With Crohn's Disease Than General Population: A Nationwide Cohort Study in Sweden 2006–2021 Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2025-06-01
Mehdi Osooli, Siri Voghera, Gustaf Bruze, Caroline Nordenvall, , Hamed Khalili, Charlotte Hedin, Pär Myrelid, Åsa H. Everhov, Jonas F. Ludvigsson, Ola Olén -
Underdiagnosis of Alpha-1 Antitrypsin Deficiency in Cirrhotic Liver Transplant Candidates: Findings From a Multicenter Retrospective Study Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2025-05-30
Manon Evain, Isaac Ruiz, Teresa Antonini, Guillaume Lassailly, Alessandra Mazzola, Pauline Houssel Debry, Laure Elkrief, Rodolphe Anty, Mylène Sebagh, Philippe Ichai, Daniel Cherqui, Didier Samuel, Ilias Kounis, Audrey Coilly -
Presentation of the AGA William Beaumont Prize in Gastroenterology to Evan S. Dellon, MD, MPH Gastroenterology (IF 25.7) Pub Date : 2025-06-02
Robert S. Sandler, Nicholas J. ShaheenSection snippets Background and FamilyEvan was born and raised in Baltimore, Maryland. His father, a prominent plastic surgeon and microsurgeon, is considered a pioneer in the field of peripheral nerve injury, and in private practice, he was promoted to full professor of plastic surgery and neurosurgery at Johns Hopkins University. His mother, originally a teacher, dedicated herself to raising Evan
-
An often-forgotten complication of upadacitinib Gastroenterology (IF 25.7) Pub Date : 2025-06-02
Phillip Te, Richard Standish, Neel HeerasingNo Abstract
-
A Case of Chronic Gastrointestinal Symptoms: Peeling Back the Mucosal Layers Gastroenterology (IF 25.7) Pub Date : 2025-06-02
Jeffrey Liu, Katherine O. Jones, Muhammad Baraa HammamiNo Abstract
-
An Unusual Cause of Secondary Sclerosing Cholangitis: A Case Report Gastroenterology (IF 25.7) Pub Date : 2025-06-02
Qianyi Wang, Jidong Jia, Xinyan ZhaoNo Abstract
-
Presentation of the 2025 AGA Distinguished Achievement Award in Basic Science to Eugene B. Chang, MD, AGAF Gastroenterology (IF 25.7) Pub Date : 2025-06-02
R.Balfour sartor, Mrinalini C. Rao, Averil MaSection snippets Impactful Body of Basic Research DiscoveriesDriven by his innate curiosity and investigative skills, Gene’s scientific accomplishments offer a remarkable compendium understanding the mechanisms involved in dynamic dialogues between microbes and hosts in diarrheal/inflammatory disorders, food allergies, type 1 diabetes, cancer, and metabolic diseases (eg, obesity, type 2 diabetes, and
-
Prioritizing inflammatory bowel disease Nat. Rev. Gastroenterol. Hepatol. (IF 45.9) Pub Date : 2025-06-02
Inflammatory bowel disease remains a global health challenge, despite advances in treatment and understanding of disease biology. In this issue, we focus on the most pressing priorities in inflammatory bowel disease research and care.
-
Bacteria-metabolite butyrate boosts anti-PD1 efficacy in colorectal cancer patient-derived organoids through activating autologous tumour-infiltrating GNLY+CD8+ T cells Gut (IF 23.0) Pub Date : 2025-06-01
Yongxin Zhang, Wu Song, Lei Zhou, Shuwen Wei, Lixia Xu, Xiaoxing Li, Jun YuWe have recently reported the immune-promoting effects of butyrate in microsatellite stable (MSS) colorectal cancer (CRC) based on mouse models.1 However, its potential application in human CRC and the underlying mechanisms by which butyrate interacts with specific CD8+ T cell subsets to regulate immunity in MSS-CRC warrant further investigation. In this study, we established a co-culture system using
-
CD300A+CD8+ T Cells as Predictive Biomarkers for Achieving Functional Cure in Chronic Hepatitis B Patients Undergoing Pegylated Interferon‐Alpha Therapy Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2025-06-02
Peng Zhang, Wen‐Xin Wang, Jing Li, Qiaolan Lv, Meng‐Meng Zhu, You‐Yuan Wang, Ming‐Ju Zhou, Si‐Yuan Chen, Yan‐Mei Jiao, Xing Fan, Jin‐Wen Song, Ruonan Xu, Cheng Zhen, Ming Shi, Fu‐Sheng Wang, Junliang Fu, Chao Zhang -
Tulisokibart shows promise for Crohn's disease Gastroenterol. Hepatol. (IF 30.9) Pub Date : 2025-05-30
James LindsayNo Abstract
-
Safety and efficacy of the anti-TL1A monoclonal antibody tulisokibart for Crohn's disease: a phase 2a induction trial Gastroenterol. Hepatol. (IF 30.9) Pub Date : 2025-05-30
Brian G Feagan, Bruce E Sands, Corey A Siegel, Marla C Dubinsky, Randy S Longman, João Sabino, Olivier Laurent, Allison Luo, Jiandong Lu, Deanna D Nguyen, Ernesto J Muñoz-Elias, Heather Llewellyn, Yong Wang, InSock Jang, Janine Bilsborough, Ron Marchelletta, Fadi Towfic, Mark Yen, Jaclyn K Anderson, Aaron DuVall, Dermot P B McGovernBackgroundTNF-like cytokine 1A (TL1A) is a key mediator of inflammation and fibrosis. The efficacy and safety of the anti-TL1A monoclonal antibody tulisokibart as induction treatment was assessed in adults with moderately to severely active Crohn's disease with a history of insufficient response, loss of response, or intolerance to conventional or approved biological therapies. MethodsIn the phase
-
Shunting the Diagnosis of a Rapid Decline in Cognition Gastroenterology (IF 25.7) Pub Date : 2025-05-31
Maria Rosina Troppmair, Benedikt Schaefer, Martin FreundNo Abstract
-
Editorial: Chronic Hepatitis B at the Intersection of Immigration, Acculturation, and Social Determinants of Health—Authors' Reply Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2025-05-31
Kali Zhou, Christine C. HsuWe appreciate the commentary provided by Drs. Hoang and Ko on our study and appreciate the summary they have provided [1, 2]. We want to highlight and discuss several important considerations in our study. We acknowledge Drs. Hoang and Ko's comment that our FOCUS-HBV cohort was a highly selected cohort and potentially not generalisable to an unlinked immigrant chronic hepatitis B population in the
-
Editorial: Chronic Hepatitis B at the Intersection of Immigration, Acculturation and Social Determinants of Health Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2025-05-31
Thomas Hoang, Hin Hin KoIt is well-known that the burden of chronic hepatitis B (CHB) in Western countries is disproportionally shouldered by their immigrant populations [1, 2]. In the United States, it is estimated that 60%–90% of CHB seroprevalence is attributed to its foreign-born (FB) population [3]. Despite this high disease prevalence, data characterising this growing population have been limited to retrospective cohorts
-
Standardising HBV nomenclature: a call to action from the HBV Forum Gastroenterol. Hepatol. (IF 30.9) Pub Date : 2025-05-29
Su Wang, Mitchell Leus, Markus Cornberg, Marc Ghany, Carey Hwang, Seng Gee Lim, Brian McMahon, C Wendy Spearman, Veronica MillerNo Abstract
-
A rare cause of abdominal distension in infancy Gastroenterology (IF 25.7) Pub Date : 2025-05-30
Yu-Syuan Chen, Jui-Hung Weng, Shan-Ming ChenNo Abstract
-
Expanding Nutrition Training in Gastroenterology: A Call to Action Gastroenterology (IF 25.7) Pub Date : 2025-05-30
Jason C. Lin, John C. Lin, Joy Zhao, Elizabeth G. Holt, Edwin K. McDonald, Stephanie M. MoleskiNo Abstract
-
Human microbiota influence the immune cell composition and gene expression in the tumor environment of a murine model of glioma Gut Microbes (IF 12.2) Pub Date : 2025-05-30
George B. H. Green, Alexis N. Cox-Holmes, Gillian H. Marlow, Anna Claire E. Potier, Yong Wang, Lianna Zhou, Dongquan Chen, Casey D. Morrow, Braden C. McFarland -
Mepolizumab Improves Histologic Severity as Measured by the EoEHSS in Adolescents and Adults With Eosinophilic Oesophagitis in a Multicenter, Randomised, Double‐Blind, Placebo‐Controlled Clinical Trial Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2025-05-30
Joseph L. Maniaci, Alina Iuga, Christine E. Bookhout, Lindsay M. Cortright, Kacie B. Walker, Susan E. Moist, Kathryn A. Peterson, Benjamin L. Mitlyng, Evan S. Dellon -
Effect of Nucleos(t)ide Analogues Withdrawal on Survival Outcomes in Patients With Hepatitis B Virus‐Related Acute‐on‐Chronic Liver Failure Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2025-05-30
Yanxue Lin, Xueping Yu, Huimin Lin, Jiajia Han, Yan Yan, Xiaoting Zhao, Yijie Lin, Zixuan Huang, Yinyin Zheng, Yahong Gao, Wenjin Yuan, Meifang Zhou, Jiming Zhang, Dawu Zeng -
Relationship of Intra-Pancreatic Fat Deposition With Pancreatic Cancer Differs According to Carcinoma Types Gastroenterology (IF 25.7) Pub Date : 2025-05-28
Hiroki Oyama, Tsuyoshi Hamada, Daniel Nevo, Yudai Nakai, Yousuke Nakai, Maxim S. Petrov -
An International Consensus on Appropriate Management of Corticosteroids in Clinical Trials in Inflammatory Bowel Disease Gastroenterology (IF 25.7) Pub Date : 2025-05-28
Jurij Hanžel, Virginia Solitano, Sudheer Kumar Vuyyuru, Remo Panaccione, Bruce E. Sands, Laurent Peyrin-Biroulet, Silvio Danese, Geert R. D'Haens, Raja Atreya, Matthieu Allez, Charles N. Bernstein, Peter Bossuyt, Brian Bressler, Robert V. Bryant, Benjamin L. Cohen, Jean-Frederic Colombel, Ferdinando D’Amico, Axel Dignass, Marla Dubinsky, Phillip Fleshner, Christopher Ma -
Gastrointestinal microbiota and inflammasomes interplay in health and disease: a gut feeling Gut (IF 23.0) Pub Date : 2025-05-28
Roberto De Luca, Valentina Arrè, Stefano Nardone, Sandra Incerpi, Gianluigi Giannelli, Pankaj Trivedi, Eleni Anastasiadou, Roberto NegroThe intricate interplay between the gut microbiota and the GI tract has garnered significant attention, as growing evidence has identified the inflammasome as a crucial yet underexplored master regulator in microbiota-driven diseases. Triggered by a variety of dangers, inflammasomes are supramolecular complexes that regulate immune response. A large number of bacterial-derived inducers have been characterised
-
Commensal Bacteroides T6SS alleviate GI-aGVHD via mediating gut microbiota composition and bile acids metabolism Gut (IF 23.0) Pub Date : 2025-05-28
Pengfei Li, Qiyi Lei, Xinghao Yu, Ying Shen, Yiyin Chen, Chang Hou, Bo Hu, Yanfang Cui, Zhihua Liu, Yi Qin, Haiyan Liu, Dandan Lin, Yang Xu, Depei WuBackground Gastrointestinal acute graft-versus-host disease (GI-aGVHD) is one of the main complications of patients undergoing allogenic haematopoietic stem cell transplantation (allo-HSCT). A deeper understanding of the mechanisms of sustaining intestinal homeostasis is essential. Objective Here, we investigated micro-organisms and microbial metabolites that were crucial for intestinal homeostasis
-
A black liver Gut (IF 23.0) Pub Date : 2025-05-28
Huang XingA 72-year-old man diagnosed with rectal adenocarcinoma underwent laparoscopic radical resection with prophylactic loop ileostomy in our department. Following the surgery, the patient completed four cycles of adjuvant chemotherapy with the XELOX regimen (capecitabine plus oxaliplatin) in accordance with the current treatment guidelines. During the scheduled stoma reversal procedure, intraoperative exploration
-
PEG Tube Gone Rogue: An Unusual Cause of Acute Pancreatitis. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-05-29
Akshay Venugopal,Akhil Baby,Shubham Suryavanshi,Rajesh Sasidharan -
Pill Esophagitis Resulting in Esophageal Mucosal Dissection and Stricture. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-05-29
Zhiren Wang,Yifeng Zheng -
Primary Biliary Cholangitis in 2025: A New Frontier. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-05-29
Hannah Klatzkow,Indira Bhavsar-Burke,Meredith Pearson,Brian J Wentworth -
A Practical Guide to Incorporating a Psychologist into a Gastroenterology Practice Gastroenterology (IF 25.7) Pub Date : 2025-05-28
Jessica K. Salwen-Deremer, Sarah Ballou, Megan Petrik, Miguel Regueiro, Corey A. Siegel, Laurie KeeferNo Abstract
-
AAV-mediated silencing of Sox4 leads to long-term amelioration of liver phenotypes in mouse models of Alagille syndrome Gastroenterology (IF 25.7) Pub Date : 2025-05-28
Duncan Fox, Jun Xie, Jennifer L. Burwinkel, Josh M. Adams, Kashish Chetal, Marzieh Keivandarian, Yaniv Faingelernt, Sanjay Subramanian, Mario F. Lopez, Anna L. Peters, Nathan Salomonis, Neda Zarrin-Khameh, Guangping Gao, Stacey S. Huppert, Hamed Jafar-Nejad -
A Pragmatic Trial Comparing Uptake and Cancer Mortality between Invitation to Colonoscopy and Invitation to Fecal Immunochemical Testing Approaches Gastroenterology (IF 25.7) Pub Date : 2025-05-28
Nauzer ForbesNo Abstract
-
Correction: Fatty acids promote fatty liver disease via the dysregulation of 3-mercaptopyruvate sulfurtransferase/hydrogen sulfide pathway Gut (IF 23.0) Pub Date : 2025-05-28
BMJ Publishing Group Ltd and British Society of GastroenterologyLi M, Xu C, Shi J, et al . et al Fatty acids promote fatty liver disease via the dysregulation of 3-mercaptopyruvate sulfurtransferase/hydrogen sulfide pathway. Gut 2018;67:2169–80. This article has …
-
The Augmented Colonoscopy with Computer-Aided polyp Characterization (AC-CADx) study - prospective study comparing the diagnostic reliability of optical diagnosis of trainees with experts without AI. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-05-28
Sebastian Bernhofer,Julian Prosenz,Christine Duller,David Venturi,Andreas MaieronINTRODUCTION Optical diagnosis is an essential part of a high-quality colonoscopy, but highly experience-dependent. Artificial intelligence in the form of computer-aided diagnosis (CADx) may bridge the gap between trainee endoscopists and experts. The aim of this study is to evaluate the diagnostic reliability of optical diagnosis of trainee endoscopists with the help of AI compared to experts. PATIENTS
-
Functional Dyspepsia and Its Subgroups: Prevalence and Impact in the Rome IV Global Epidemiology Study Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2025-05-28
J. Tack, O. S. Palsson, S. I. Bangdiwala, J. Schol, F. Carbone, K. Van Den Houte, B. Broeders, D. Drossman, D. L. Dumitrascu, X. Fang, S. Fukudo, U. C. Ghoshal, J. Kellow, R. Khatun, E. Okeke, E. M. Quigley, M. Schmulson, M. Simrén, W. E. Whitehead, P. Whorwell, A. D. Sperber -
Efficacy of ACupuncTure in Irritable bOwel syNdrome (ACTION): a multi-centre randomized controlled trial Gastroenterology (IF 25.7) Pub Date : 2025-05-27
Jing-Wen Yang, Ling-Yu Qi, Shi-Yan Yan, Yan-Fen She, Ying Li, Li-Li Chi, Hui Hu, Li-Qiong Wang, Chang-Chun Ji, Bang-Qi Wu, Zi-Tong Fu, Shuang-Jing Li, Na-Na Yang, Yu Wang, Cun-Zhi LiuBACKGROUND & AIMSIrritable bowel syndrome (IBS) affects 4.1% of the adult population, with many reporting ongoing symptoms despite first-line therapies. Acupuncture is widely used for IBS, but without sufficient evidence. We aim to assess the efficacy of acupuncture in patients with diarrhea-predominant IBS (IBS-D). METHODSThis was a multi-center randomized controlled trial in six hospitals in China
-
Microbiome signatures of virulence in the oral-gut-brain axis influence Parkinson’s disease and cognitive decline pathophysiology Gut Microbes (IF 12.2) Pub Date : 2025-05-27
Frederick Clasen, Suleyman Yildirim, Muzaffer Arıkan, Fernando Garcia-Guevara, Lűtfű Hanoğlu, Nesrin H. Yılmaz, Aysu Şen, Handan Kaya Celik, Alagoz Aybala Neslihan, Tuǧçe Kahraman Demir, Zeynep Temel, Adil Mardinoglu, David L. Moyes, Mathias Uhlen, Saeed Shoaie -
Listening Beyond the Symptoms: Existential Needs and Identity in Older Adults With Inflammatory Bowel Disease. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-05-27
Partha Pal -
Effect of 3-day linaclotide administration to reduce the PEG volume for colonoscopy bowel preparation: A multicenter, noninferiority, randomized controlled trial. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-05-27
Peng Pan,Huixin Chen,Tongchang Wang,Kaijun Liu,Biguang Tuo,Rong Wang,Hongyu Fu,Chunmeng Jiang,Lisha Chen,Qiu Zhao,Wen Wang,Weigang Chen,Qiang Guo,Weichang Chen,Yanqing Li,Zibin Tian,Zhijie Feng,Shaoqi Yang,Yi Fan,Fujuan Luan,Youxiang Chen,Zhaoshen Li,Yu BaiOBJECTIVES Several studies have investigated the role of linaclotide in bowel preparation; however, dosage and timing still warrant further exploration. METHODS This non-inferiority randomized controlled study was performed in sixteen medical centers. The eligible subjects were randomly assigned to three groups: the Lct + 3 L PEG group (Group A), the 3 L PEG group (Group B), or the Lct + 2 L PEG group
-
Issue Information Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2025-05-27
Click on the article title to read more.
-
New insights in amino sugar metabolism by the gut microbiome Gut Microbes (IF 12.2) Pub Date : 2025-05-26
Wenqiang Shen, Jan Freark de Boer, Folkert Kuipers, Jingyuan FuGut microorganisms inhabiting the intestinal tract play key roles in host's health and disease. A properly functioning gut microbiome requires the availability of adequate carbon, nitrogen and energy sources. One of the main sources of energy for intestinal bacteria are glycans, of which amino sugars are important components. Amino sugars are a class of carbohydrates in which one or more hydroxyl groups